COVID-KOSHA
Home
Comment
A model anti-pandemic portal for scientists & public
set1
set2
set3
Choose the topic:
Sequence
Structure
Clinical Trials and Similar Human Studies
Diagnostics
Drug Studies-in vitro
Drugs in silico
Drug studies in humans
Drug studies in animals
Epidemiology
Hospital/patient management
Immunology
Molecular Interactions
Pathophysiology
Drug Studies-in vitro
Symptoms
High priority articles (R1, Most articles most likely to be relevant):
Sequence
Last updated: 2024 Apr 18
Total hit(s): 6227
S.No.
PMID
Ascending order
Descending order
Title
Ascending order
Descending order
Journal Name
Ascending order
Descending order
Publish Date
Ascending order
Descending order
Impact Factor
Ascending order
Descending order
Citations
Ascending order
Descending order
1
38575149
Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineages.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
2
38377136
Effectiveness of a broad-spectrum bivalent mRNA vaccine against SARS-CoV-2 variants in preclinical studies.
Emerg Microbes Infect
2024 Dec
5.84
1
3
38183475
Development of multiplex allele-specific RT-qPCR assays for differentiation of SARS-CoV-2 Omicron subvariants.
Appl Microbiol Biotechnol
2024 Dec
3.82
1
4
38524302
Alternative genome sequencing approaches of SARS-CoV-2 using Ion AmpliSeq Technology.
MethodsX
2024 Jun
1
5
38574505
Diverse pro-inflammatory ability of mutated spike protein derived from variant strains of SARS-CoV-2.
Cytokine
2024 Jun
2.88
1
6
38431405
Fucoidan from Ascophyllum nodosum and Undaria pinnatifida attenuate SARS-CoV-2 infection in vitro and in vivo by suppressing ACE2 and alleviating inflammation.
Carbohydr Polym
2024 May 15
6.23
1
7
38589848
Expression of the SARS-CoV-2 receptor-binding domain by live attenuated influenza vaccine virus as a strategy for designing a bivalent vaccine against COVID-19 and influenza.
Virol J
2024 Apr 9
2.45
1
8
38592189
Prediction of deleterious non-synonymous SNPs of TMPRSS2 protein combined with Molecular Dynamics Simulations and free energy analysis to identify the potential peptide substrates against SARS-CoV-2.
J Biomol Struct Dyn
2024 Apr 9
3.22
1
9
38591881
The potentiality of bacteria to drive SARS-CoV-2 mutation.
mBio
2024 Apr 9
6.5
1
10
38589755
Dynamic Patterns and Predominance of Respiratory Pathogens Post-COVID-19: Insights from a Two-Year Analysis.
J Epidemiol Glob Health
2024 Apr 8
3.7
1
11
38587722
Analysis of SARS-CoV-2 omicron mutations that emerged during long-term replication in a lung cancer xenograft mouse model.
Virus Genes
2024 Apr 8
4.2
1
12
38593595
Eight-amino-acid sequence at the N-terminus of SARS-CoV-2 nsp1 is involved in stabilizing viral genome replication.
Virology
2024 Apr 8
2.819
1
13
38580714
COVID-19 vaccination induces distinct T-cell responses in pediatric solid organ transplant recipients and immunocompetent children.
NPJ Vaccines
2024 Apr 5
4.98
1
14
38582657
A comparative analysis of TCR immune repertoire in COVID-19 patients.
Hum Immunol
2024 Apr 5
1.95
1
15
38583778
Evidence from Whole Genome Sequencing of Aerosol Transmission of SARS-CoV-2 almost Five Hours after Hospital Room Turnover.
Am J Infect Control
2024 Apr 5
2.03
1
16
38617283
Predicting Functional Conformational Ensembles and Binding Mechanisms of Convergent Evolution for SARS-CoV-2 Spike Omicron Variants Using AlphaFold2 Sequence Scanning Adaptations and Molecular Dynamics Simulations.
bioRxiv
2024 Apr 3
- n/a -
1
17
38574833
Relative frequency of genomic mutations in SARS-CoV-2 recovered from southern Brazilian cases of COVID-19 through the Gamma, Delta and Omicron waves.
Infect Genet Evol
2024 Apr 3
2.67
1
18
38564711
A novel fast hybrid capture sequencing method for high-efficiency common human coronavirus whole-genome acquisition.
mSystems
2024 Apr 2
6.28
1
19
38617221
Distal Protein-Protein Interactions Contribute to SARS-CoV-2 Main Protease Substrate Binding and Nirmatrelvir Resistance.
bioRxiv
2024 Apr 2
- n/a -
1
20
38565591
Detection of SARS-COV-2 variants and their proportions in wastewater samples using next-generation sequencing in Finland.
Sci Rep
2024 Apr 2
4.12
1
21
38565881
SARS-CoV-2 variant with the spike protein mutation F306L in the southern border provinces of Thailand.
Sci Rep
2024 Apr 2
4.12
1
22
38599031
Porcine respiratory coronavirus genome sequences; comparisons and relationships to transmissible gastroenteritis viruses.
Virology
2024 Apr 2
2.819
1
23
38632311
Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infection.
Nat Commun
2024 Apr 17
11.8
1
24
38632240
SARS-CoV-2 remodels the landscape of small non-coding RNAs with infection time and symptom severity.
NPJ Syst Biol Appl
2024 Apr 17
1
25
38624232
Epitopes of an antibody that neutralizes a wide range of SARS-CoV-2 variants in a conserved subdomain 1 of the spike protein.
J Virol
2024 Apr 16
4.16
1